Lupin releases generic Myrbetriq
Generic Myrbetriq is used to treat overactive bladder symptoms.
Lupin is launching mirabegron ER tablets, 50 mg, which is a generic of Astellas Pharma’s Myrbetriq.
Myrbetriq is used to treat overactive bladder with symptoms of urgency, frequency and leakage in adults.
[Read more: Lupin receives FDA nod for 3 generics]
Mirabegron ER Tablets, 50 mg had a market value of roughly 1.6 billion, per July 2024 IQVIA data.
[Read more: Lupin receives FDA OK for generic Banzel]